{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:01:32Z","timestamp":1780304492226,"version":"3.54.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01894-0","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:28:14Z","timestamp":1780298894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the potential targets and mechanisms of artemisinin in the treatment of diabetic kidney disease using network pharmacology and molecular docking"],"prefix":"10.1007","volume":"26","author":[{"given":"Hongning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"1894_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s44371-025-00084-4","volume":"2","author":"TA Addissouky","year":"2025","unstructured":"Addissouky TA (2025) Artemisinin and its derivatives throughout the therapeutic mechanisms and clinical potential. Discover Chem 2:10","journal-title":"Discover Chem"},{"key":"1894_CR29","doi-asserted-by":"publisher","first-page":"e280322202705","DOI":"10.2174\/1573399818666220328145046","volume":"19","author":"MM Adeva-Andany","year":"2023","unstructured":"Adeva-Andany MM, Adeva-Contreras L, Fern\u00e1ndez-Fern\u00e1ndez C, Carneiro-Freire N, Dom\u00ednguez-Montero A (2023) Histological Manifestations of Diabetic Kidney Disease and its Relationship with Insulin Resistance. Curr Diabetes Rev 19:e280322202705","journal-title":"Curr Diabetes Rev"},{"key":"1894_CR39","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41467-024-45499-2","volume":"15","author":"MP Chakraborty","year":"2024","unstructured":"Chakraborty MP, Das D (2024) Molecular basis of VEGFR1 autoinhibition at the plasma membrane. Nat Commun 15:1346","journal-title":"Nat Commun"},{"key":"1894_CR38","doi-asserted-by":"publisher","first-page":"1499473","DOI":"10.3389\/fmed.2024.1499473","volume":"11","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, Tumarin J, Prabhakar S (2024) Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease. Front Med (Lausanne) 11:1499473","journal-title":"Front Med (Lausanne)"},{"key":"1894_CR7","doi-asserted-by":"publisher","first-page":"177543","DOI":"10.1016\/j.ejphar.2025.177543","volume":"998","author":"C Chen","year":"2025","unstructured":"Chen C, Xu B, Li W et al (2025) New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy. Eur J Pharmacol 998:177543","journal-title":"Eur J Pharmacol"},{"key":"1894_CR28","doi-asserted-by":"publisher","first-page":"103127","DOI":"10.1016\/j.redox.2024.103127","volume":"72","author":"M Chen","year":"2024","unstructured":"Chen M, Fang Y, Ge Y et al (2024) The redox-sensitive GSK3\u03b2 is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease. Redox Biol 72:103127","journal-title":"Redox Biol"},{"key":"1894_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/a-2435-8264","volume":"57","author":"S Dwivedi","year":"2025","unstructured":"Dwivedi S, Sikarwar MS (2025) Diabetic nephropathy: pathogenesis, mechanisms, and therapeutic strategies. Horm Metab Res 57:7\u201317","journal-title":"Horm Metab Res"},{"key":"1894_CR19","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.curpro.2025.100017","volume":"22","author":"B Feng","year":"2025","unstructured":"Feng B, Liang J, Cai X et al (2025) Elucidating the therapeutic mechanisms of Angelica dahurica in knee osteoarthritis: An integrative network pharmacology and molecular docking approach. Curr Proteomics 22:100017","journal-title":"Curr Proteomics"},{"key":"1894_CR42","doi-asserted-by":"publisher","first-page":"42333","DOI":"10.1038\/s41598-025-26361-x","volume":"15","author":"C Feng","year":"2025","unstructured":"Feng C, Chun L, KeLei S et al (2025) Exploring the mechanism of plasticizers action in liver damage based on network toxicology, molecular docking, and molecular dynamic simulation. Sci Rep 15:42333","journal-title":"Sci Rep"},{"key":"1894_CR47","doi-asserted-by":"publisher","first-page":"5401760","DOI":"10.1155\/2022\/5401760","volume":"2022","author":"H Feng","year":"2022","unstructured":"Feng H, Wu T (2022) Protective effect and possible mechanisms of artemisinin and its derivatives for diabetic nephropathy: a systematic review and meta-analysis in animal models. Oxid Med Cell Longev 2022:5401760","journal-title":"Oxid Med Cell Longev"},{"key":"1894_CR6","first-page":"1","volume":"17","author":"SP Georgios","year":"2024","unstructured":"Georgios SP (2024) SGLT2 Inhibitors and diabetic kidney disease: targeting multiple and interrelated signaling pathways for renal protection. Curr Mol Pharmacol 17:1\u201326","journal-title":"Curr Mol Pharmacol"},{"key":"1894_CR18","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.lddd.2025.100018","volume":"22","author":"Y Han","year":"2025","unstructured":"Han Y, Chen Y, Xiao X et al (2025) Exploring the mechanism of Grifolin in inhibiting the malignant progression of colon cancer cells mediated by the PDGFRB\/PI3K\/AKT signaling pathway based on bioinformatics analysis and network pharmacology. Lett Drug Des Discovery 22:100018","journal-title":"Lett Drug Des Discovery"},{"key":"1894_CR4","doi-asserted-by":"publisher","first-page":"1602594","DOI":"10.3389\/fendo.2025.1602594","volume":"16","author":"G Hou","year":"2025","unstructured":"Hou G, Dong Y, Jiang Y et al (2025) Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy. Front Endocrinol (Lausanne) 16:1602594","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1894_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/mmr.2025.13487","volume":"31","author":"M Huang","year":"2025","unstructured":"Huang M, Chang J, Liu Y, Yin J, Zeng X (2025) Apelin\/APJ alleviates diabetic nephropathy by improving glomerular endothelial cells dysfunction via SIRT3\u2013KLF15. Mol Med Rep 31:122","journal-title":"Mol Med Rep"},{"key":"1894_CR37","doi-asserted-by":"publisher","first-page":"1097206","DOI":"10.3389\/fphar.2023.1097206","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Chen D et al (2023) Therapeutic potential of artemisinin and its derivatives in managing kidney diseases. Front Pharmacol 14:1097206","journal-title":"Front Pharmacol"},{"key":"1894_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1871530323666230901164219","volume":"24","author":"M Kaushik","year":"2024","unstructured":"Kaushik M, Kaushik A, Chaudhary J, Jain A (2024) Terpenoids in diabetic nephropathy: advances and therapeutic opportunities. Endocr Metab Immune Disord Drug Targets 24:13\u201330","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1894_CR16","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1111\/dom.16536","volume":"27","author":"K Li","year":"2025","unstructured":"Li K, Tang H, Wang Y (2025) Identification of hub genes involved in the pathogenesis of diabetic nephropathy: A multi-omics study integrating machine learning, mendelian randomization and mediation analysis. Diabetes Obes Metab 27:4927\u20134941","journal-title":"Diabetes Obes Metab"},{"key":"1894_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10020-021-00365-5","volume":"27","author":"M Li","year":"2021","unstructured":"Li M, Deng L, Xu G (2021) METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of \u03b1-klotho. Mol Med 27:106","journal-title":"Mol Med"},{"key":"1894_CR26","doi-asserted-by":"publisher","first-page":"100598","DOI":"10.1016\/j.jgeb.2025.100598","volume":"23","author":"S Li","year":"2025","unstructured":"Li S, Wang H, Zhang Y (2025) Bioinformatics and experimental validation of MAPK pathway activation in diabetic kidney disease induced by glucose variability. J Genet Eng Biotechnol 23:100598","journal-title":"J Genet Eng Biotechnol"},{"key":"1894_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/ph18040535","volume":"18","author":"C Liu","year":"2025","unstructured":"Liu C, Liu X, Duan J (2025) Artemisinin and its derivatives: promising therapeutic agents for age-related macular degeneration. Pharmaceuticals (Basel) 18:535","journal-title":"Pharmaceuticals (Basel)"},{"key":"1894_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7150\/ijbs.89291","volume":"20","author":"S Liu","year":"2024","unstructured":"Liu S, Han S, Wang C et al (2024) MAPK1 Mediates MAM disruption and mitochondrial dysfunction in diabetic kidney disease via the PACS-2-dependent mechanism. Int J Biol Sci 20:569\u2013584","journal-title":"Int J Biol Sci"},{"key":"1894_CR48","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1002\/ptr.70091","volume":"39","author":"Z Liu","year":"2025","unstructured":"Liu Z, Hu H, Jin Y et al (2025) Artesunate enhances DUSP1-dependent mitochondrial integrity to mitigate renal fibrosis in diabetic kidney disease. Phytother Res 39:5085\u20135101","journal-title":"Phytother Res"},{"key":"1894_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","volume":"22","author":"V Martinez Leon","year":"2026","unstructured":"Martinez Leon V, Hilburg R, Susztak K (2026) Mechanisms of diabetic kidney disease and established and emerging treatments. Nat Rev Endocrinol 22:21\u201335","journal-title":"Nat Rev Endocrinol"},{"key":"1894_CR44","doi-asserted-by":"publisher","first-page":"e0207921","DOI":"10.1128\/aac.02079-21","volume":"66","author":"CM Moore","year":"2022","unstructured":"Moore CM, Wang J, Lin Q et al (2022) Selective inhibition of plasmodium falciparum ATPase 6 by artemisinins and identification of new classes of inhibitors after expression in yeast. Antimicrob Agents Chemother 66:e0207921","journal-title":"Antimicrob Agents Chemother"},{"key":"1894_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/B978-0-323-88426-6.00012-9","volume":"2024","author":"E Pardina","year":"2024","unstructured":"Pardina E, Tondo M, Escol\u00e0-Gil JC et al (2024) Molecular mechanisms involved in hyperglycemia-induced cellular damage. Chronic Complications Diabetes Mellitus 2024:25\u201338","journal-title":"Chronic Complications Diabetes Mellitus"},{"key":"1894_CR25","doi-asserted-by":"publisher","first-page":"157668","DOI":"10.1016\/j.phymed.2025.157668","volume":"150","author":"F Pei","year":"2025","unstructured":"Pei F, Duan J, Tan L et al (2025) Swietenine attenuates renal tubular injury by activating mitophagy in diabetic nephropathy. Phytomedicine 150:157668","journal-title":"Phytomedicine"},{"key":"1894_CR35","first-page":"591","volume":"25","author":"A Sanglard","year":"2025","unstructured":"Sanglard A, Miranda BCB (2025) The role of renin-angiotensin system in diabetic nephropathy: an update Mini Rev Med Chem 25:591\u201360","journal-title":"Update"},{"key":"1894_CR12","doi-asserted-by":"publisher","first-page":"e18761429244886","DOI":"10.2174\/0118761429244886230927070818","volume":"17","author":"R Song","year":"2024","unstructured":"Song R, Xiong C, Bai J, Bai Z, Liu W (2024) Artemisinin attenuates isoproterenol-induced cardiac hypertrophy via the ERK1\/2 and p38 MAPK signaling pathways. Curr Mol Pharmacol 17:e18761429244886","journal-title":"Curr Mol Pharmacol"},{"key":"1894_CR3","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S et al (2022) IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119","journal-title":"Diabetes Res Clin Pract"},{"key":"1894_CR33","doi-asserted-by":"publisher","first-page":"112156","DOI":"10.1016\/j.mce.2024.112156","volume":"584","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang Q, Dong W et al (2024) SGLT2 knockdown restores the Th17\/Treg balance and suppresses diabetic nephropathy in db\/db mice by regulating SGK1 via Na+. Mol Cell Endocrinol 584:112156","journal-title":"Mol Cell Endocrinol"},{"key":"1894_CR43","doi-asserted-by":"publisher","first-page":"114958","DOI":"10.1016\/j.intimp.2025.114958","volume":"160","author":"L Wang","year":"2025","unstructured":"Wang L, Zhao B, Wang J et al (2025) Epigollatecatechin gallate alleviates rheumatoid arthritis through PI3K-Akt pathway by inhibiting FLT1. Int Immunopharmacol 160:114958","journal-title":"Int Immunopharmacol"},{"key":"1894_CR46","doi-asserted-by":"publisher","first-page":"656115","DOI":"10.3389\/fphar.2021.656115","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang S, Tang C, Zhao H et al (2021) Network pharmacological analysis and experimental validation of the mechanisms of action of Si-Ni-San against liver fibrosis. Front Pharmacol 12:656115","journal-title":"Front Pharmacol"},{"key":"1894_CR23","doi-asserted-by":"publisher","first-page":"112292","DOI":"10.1016\/j.diabres.2025.112292","volume":"226","author":"ZA Wani","year":"2025","unstructured":"Wani ZA, Ahmed S, Saleh A et al (2025) Biomarkers in diabetic nephropathy: A comprehensive review of their role in early detection and disease progression monitoring. Diabetes Res Clin Pract 226:112292","journal-title":"Diabetes Res Clin Pract"},{"key":"1894_CR10","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.2147\/DDDT.S545163","volume":"19","author":"D Wu","year":"2025","unstructured":"Wu D, Zeng H, Tan J et al (2025) Repurposing artemisinin-based drugs from antimalarial to pan-therapeutic: pharmacological promise and therapeutic challenges. Drug Des Devel Ther 19:9199\u20139226","journal-title":"Drug Des Devel Ther"},{"key":"1894_CR20","doi-asserted-by":"publisher","first-page":"1427626","DOI":"10.3389\/fimmu.2024.1427626","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu X, Guo B, Chang X et al (2024) Identification and validation of glycolysis-related diagnostic signatures in diabetic nephropathy: a study based on integrative machine learning and single-cell sequence. Front Immunol 15:1427626","journal-title":"Front Immunol"},{"key":"1894_CR11","first-page":"8409","volume":"26","author":"Y Xia","year":"2025","unstructured":"Xia Y, Shi C, Lu J et al (2025) Artemisinin and its derivatives from molecular mechanisms to clinical applications. New Horizons Beyond Antimalarials 26:8409","journal-title":"New Horizons Beyond Antimalarials"},{"key":"1894_CR45","doi-asserted-by":"publisher","first-page":"1602581","DOI":"10.3389\/fphar.2025.1602581","volume":"16","author":"X Xie","year":"2025","unstructured":"Xie X, Chen Q, Guo C, Zeng J, He Q (2025) Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer. Front Pharmacol 16:1602581","journal-title":"Front Pharmacol"},{"key":"1894_CR30","doi-asserted-by":"publisher","first-page":"e70077","DOI":"10.1002\/iid3.70077","volume":"12","author":"X Xiong","year":"2024","unstructured":"Xiong X, Feng X, Ding Y (2024) Periostin induces epithelial-mesenchymal transition via p38-MAPK pathway in human renal tubular cells by high glucose. Immun Inflamm Dis 12:e70077","journal-title":"Immun Inflamm Dis"},{"key":"1894_CR14","doi-asserted-by":"publisher","first-page":"816400","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Liu Z (2022) Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne) 13:816400","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1894_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tplants.2024.09.006","volume":"30","author":"Q Yin","year":"2025","unstructured":"Yin Q, Xiang L, Han X et al (2025) The evolutionary advantage of artemisinin production by Artemisia annua. Trends Plant Sci 30:213\u2013226","journal-title":"Trends Plant Sci"},{"key":"1894_CR1","doi-asserted-by":"publisher","first-page":"1335495","DOI":"10.3389\/fendo.2025.1335495","volume":"16","author":"J Yue","year":"2025","unstructured":"Yue J, Guo J, Wang X et al (2025) Acupuncture for diabetic nephropathy: mechanisms, clinical evidence, and future perspectives. Front Endocrinol (Lausanne) 16:1335495","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1894_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/0115701646309538240805093732","volume":"21","author":"Y Yue","year":"2024","unstructured":"Yue Y, Yiying T, Jiaxin W et al (2024) Circulating exosomes studied by label-free proteomics analysis reveal transition signatures from diabetes mellitus to diabetic kidney disease. Curr Proteomics 21:187\u2013203","journal-title":"Curr Proteomics"},{"key":"1894_CR40","doi-asserted-by":"publisher","first-page":"27198","DOI":"10.1038\/s41598-024-78828-y","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang S, Wang H et al (2024) Assessing the diagnostic utility of urinary albumin-to-creatinine ratio as a potential biomarker for diabetic peripheral neuropathy in type 2 diabetes mellitus patients. Sci Rep 14:27198","journal-title":"Sci Rep"},{"key":"1894_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/08830185.2024.2321901","volume":"43","author":"T Zhang","year":"2024","unstructured":"Zhang T, Huo H, Zhang Y et al (2024) Th17 cells: A new target in kidney disease research. Int Rev Immunol 43:263\u2013279","journal-title":"Int Rev Immunol"},{"key":"1894_CR17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1080\/07391102.2023.2294165","volume":"43","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chao P, Zhang L et al (2025) Integrating network pharmacology, molecular docking and simulation approaches with machine learning reveals the multi-target pharmacological mechanism of Berberis integerrima against diabetic nephropathy. J Biomol Struct Dyn 43:2092\u20132108","journal-title":"J Biomol Struct Dyn"},{"key":"1894_CR32","first-page":"5052561","volume":"2025","author":"X Zhang","year":"2025","unstructured":"Zhang X, Li L, Xue R et al (2025) Artemether attenuates high glucose-induced inflammation and fibrogenesis in renal tubular epithelial cells by modulating the TGF-\u03b2\/Smad pathway Via PPAR\u03b3. Activation 2025:5052561","journal-title":"Activation"},{"key":"1894_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12933-025-02836-z","volume":"24","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Ge X, Chen Z et al (2025) Distinct types of protein modifications in diabetic endothelial dysfunction. Cardiovasc Diabetol 24:287","journal-title":"Cardiovasc Diabetol"},{"key":"1894_CR31","doi-asserted-by":"publisher","first-page":"e12059","DOI":"10.1002\/ccs3.12059","volume":"19","author":"S Zhu","year":"2025","unstructured":"Zhu S, Zhang M, Qu Z et al (2025) Moscatilin alleviates oxidative stress and inflammatory response of M\u00fcller cells in diabetic retinopathy through suppressing the p38 mitogen-activated protein kinase\/c-Jun N-terminal kinase and nuclear factor kappa-B signaling pathways. J Cell Commun Signal 19:e12059","journal-title":"J Cell Commun Signal"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01894-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:02:44Z","timestamp":1780300964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01894-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1894"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01894-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}